Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 5 chart positions in 5 markets.
By chart position
- 🇳🇱NL · Medicine#7110K to 30K
- 🇳🇿NZ · Medicine#4410K to 30K
- 🇹🇷TR · Medicine#893K to 10K
- 🇿🇦ZA · Medicine#164500 to 3K
- 🇨🇱CL · Medicine#173500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
12K to 38K🎙 Weekly cadence·128 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
24K to 76K🇳🇱39%🇳🇿39%🇹🇷13%+2 more - Active Followers
Loyal subscribers who consistently listen
9.6K to 30K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition
May 6, 2026
14m 42s
Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts
Apr 16, 2026
17m 16s
Managing type 2 diabetes patients with MASLD
Mar 2, 2026
20m 24s
Targeting MASLD with new nanoparticles
Feb 2, 2026
14m 58s
Performance of the China-CLIF framework in acute-on-chronic liver failure
Jan 6, 2026
15m 10s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/6/26 | Eosinophilic oesophagitis: the therapeutic potential of FOXM1 inhibition | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Amanda Muir from the Department of Gastroenterology, Hepatology, and Nutrition, The Children’s Hospital of Philadelphia, and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA, on the paper "FOXM1 inhibition reduces IL-13-induced epithelial remodelling and inflammation in eosinophilic oesophagitis" published in paper copy in Gut in May 2026. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://bit.ly/4rRJeUI). | 14m 42s | ||||||
| 4/16/26 | Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Shanshan Wu from the Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory of Digestive Health, National Clinical Research Center for Digestive Disease, Beijing, China, and Professor Yuanjie Pang from Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China, on the paper "Long-term prognosis of lean MASLD: evidence from three population-based prospective cohorts" published in paper copy in Gut in April 2026.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://bit.ly/4rRJeUI). | 17m 16s | ||||||
| 3/2/26 | Managing type 2 diabetes patients with MASLD | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Xiaolong Qi from Centre of Liver Disease, Zhongda Hospital, Southeast University, Nanjing, China on the paper "Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes" published in paper copy in Gut in March 2026.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://bit.ly/4rRJeUI). | 20m 24s | ||||||
| 2/2/26 | Targeting MASLD with new nanoparticles | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Zhi-Gang She from the State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute; School of Pharmacy; First Affiliated Hospital, Gannan Medical University, Ganzhou, China. Professor She is also the Deputy Director of the Department of Cardiology, Renmin Hospital of Wuhan University. Professor She is interviewed on the paper "Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLD" published in paper copy in Gut in February 2026. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 14m 58s | ||||||
| 1/6/26 | Performance of the China-CLIF framework in acute-on-chronic liver failure | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Jun Li from the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China on the paper "Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies" published in paper copy in Gut in January 2026.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 15m 10s | ||||||
| 12/1/25 | Predicting short-term liver transplant outcomes with graft microbial DNA signature | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Fernando Lucas-Ruiz from the Biomedical Research Institute of Murcia, Murcia, Spain on the paper "Intrahepatic donor microbiota-based metataxonomic signature detected in organ preservation solution enables prediction of short-term liver transplant outcomes" published in paper copy in Gut in December 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 15m 25s | ||||||
| 11/3/25 | Screening and eradication of H pylori for gastric cancer prevention: Taipei Global Consensus II | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Jyh-Ming Liou from Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan on the paper "Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II" published in paper copy in Gut in November 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 22m 28s | ||||||
| 10/1/25 | Helicobacter pylori antibiotic resistance: a global challenge in search of solutions | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Christian Schulz from the Medical Department 2, LMU Munich, Munich, Germany on the paper "Helicobacter pylori antibiotic resistance: a global challenge in search of solutions" published in paper copy in Gut in October 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 10m 27s | ||||||
| 9/5/25 | Effective treatment of severe acute pancreatitis using COX-2 inhibitors | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Chengwei Tang and Associate Professor Zhiyin Huang from the Department of Gastroenterology, West China Hospital of Sichuan University, Chengdu, Sichuan, China on the paper "Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial" published in paper copy in Gut in September 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 18m 01s | ||||||
| 8/1/25 | Protecting against Crohn's disease with dietary whey protein | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Tao Zuo from the Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, Guangdong, China, on the paper "Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome" published in paper copy in Gut in August 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 19m 38s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 7/1/25 | Comparing diclofenac and indomethacin for prevention of post-ERCP pancreatitis | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Yanglin Pan from the State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China, on the paper "Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial" published in paper copy in Gut in July 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 17m 27s | ||||||
| 6/2/25 | Studying oat ingestion in coeliac disease with purified oat protein | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Tye-Din from the Immunology Division, Walter and Eliza Hall Institute of Medical Research, and Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia, on the paper "Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration" published in paper copy in Gut in June 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 13m 10s | ||||||
| 5/1/25 | Predicting sensitivity to dietary emulsifiers using an in-vitro microbiota model | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Benoit Chassaing and Dr Héloïse Rytter from Microbiome-Host Interactions, INSERM, Institut Pasteur, Université Paris Cité, Paris, France, on the paper "In vitro microbiota model recapitulates and predicts individualised sensitivity to dietary emulsifier" published in paper copy in Gut in May 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 16m 55s | ||||||
| 4/1/25 | Antiviral treatment of chronic Hepatitis B | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Yao-Chun (Holden) Hsu from School of Medicine and Graduate Institute of Medicine, I-Shou University, Kaohsiung, Taiwan, on the paper "Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B" published in paper copy in Gut in April 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 12m 59s | ||||||
| 3/3/25 | Single-cell spatial profiling of immunotypes in hepatocellular carcinoma | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Bertram Bengsch and Dr Henrike Salie from the Department of Internal Medicine II, Medical Centre, University of Freiburg, Freiburg, Germany, on the paper "Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma" published in paper copy in Gut in March 2025. | 19m 47s | ||||||
| 2/4/25 | Understanding the gut-adipose-liver axis and its impact on insulin action | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Jordi Mayneris-Perxachs and Dr Anna Castells-Nobau from the Girona Biomedical Research Centre (IDIBGI), Girona, Spain, on the paper "Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism" published in paper copy in Gut in February 2025. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 13m 22s | ||||||
| 1/6/25 | Linking breastfeeding and atopic dermatitis in infants | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Suhua Jiang from the Department of Paediatrics, The First People's Hospital of Foshan, Foshan, People's Republic of China and Professor Lin Zhang, Assistant Professor from Department of Anaesthesia and Intensive Care and Lead Scientist, Microbiota I-Center (MagIC) in the Chinese University of Hong Kong, on the paper "Association of breast milk-derived arachidonic acid-induced infant gut dysbiosis with the onset of atopic dermatitis" published in paper copy in Gut in January 2025. A close transcript of this podcast is available at this link: https://bit.ly/40jF5xo Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 11m 12s | ||||||
| 12/2/24 | Improving CLDN18.2 BiTEs efficacy against pancreatic cancer | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK, interviews Professor Jihui Hao from the Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, on the paper "CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells" published in paper copy in Gut in December 2024. A close transcript of this podcast is available at this link: https://bit.ly/3Ox8Io2 Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 12m 21s | ||||||
| 11/1/24 | Gut microbiota signatures of vulnerability to food addiction in mice and humans | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Elena Martín-García and Professor Rafael Maldonado from the Laboratory of Neuropharmacology, Pompeu Fabra University and Hospital del Mar Research Institute, Barcelona, Spain and Professor Jose Manuel Fernández-Real from the Endocrinology, Nutrition, Eumetabolism & Health group, Hospital Trueta of Girona, University of Girona, Girona, Spain on the paper "Gut microbiota signatures of vulnerability to food addiction in mice and humans" published in paper copy in Gut in November 2024. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 12m 23s | ||||||
| 10/1/24 | Gastric intestinal metaplasia: reviewing current guidelines | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Mario Dinis-Ribeiro from the Department of Gastroenterology at Porto Comprehensive Cancer Center & RISE—Health Research Network, Porto, Portugal, on the paper "The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines" published in paper copy in Gut in October 2024. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 20m 06s | ||||||
| 9/2/24 | Exploring stem cell therapy for Hirschsprung disease | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Conor McCann from the Department of Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, London, UK and Dr Anestis Tsakiridis from the School of Biosciences, The University of Sheffield, Sheffield, UK on the paper "Human enteric nervous system progenitor transplantation improves functional responses in Hirschsprung disease patient-derived tissue" published in paper copy in Gut in September 2024.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 14m 01s | ||||||
| 8/1/24 | Protective function of sclerosing cholangitis on IBD | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Samuel Huber, from the Department of Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany, on the paper "Protective function of sclerosing cholangitis on IBD" published in paper copy in Gut in August 2024.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 8m 20s | ||||||
| 7/1/24 | Linking high-fat diet and liver tumorigenesis | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Jianping Guo from Institute of Precision Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China, on the paper "High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT" published in paper copy in Gut in July 2024. A close transcript of this podcast is available at this link: https://bit.ly/3zlcoVF Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 13m 46s | ||||||
| 6/3/24 | Hepatocellular carcinoma in patients with liver cirrhosis | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Hashem El-Serag from the Department of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA, on the paper "Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis" published in paper copy in Gut in June 2024. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 20m 07s | ||||||
| 5/1/24 | Microbiome interventions for COPD protection | Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Dr Kurtis Budden, from the Immune Health Program, The University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia and Professor Philip Hansbro who is also a conjoint there and the Director of the Centenary Institute and University of Technology Sydney Centre for Inflammation, Sydney, NSW, Australia, on the paper "Faecal microbial transfer and complex carbohydrates mediate protection against COPD" published in paper copy in Gut in May 2024.Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). | 12m 22s | ||||||
Showing 25 of 129
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
5 placements across 5 markets.
Chart Positions
5 placements across 5 markets.